CLINICAL TRIAL
Published on 27 Sep 2021
Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline—Results From a Randomized Controlled Clinical Trial
![Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline—Results From a Randomized Controlled Clinical Trial](https://www.frontiersin.org/files/myhome article library/615261/615261_Thumb_400.jpg)
doi 10.3389/fpsyt.2021.615261
- 3,473 views
- 16 citations